The MEA lyophilized injectable market is expected to grow from US$ 82.87 million in 2022 to US$ 101.86 million by 2028. It is estimated to grow at a CAGR of 3.5% from 2022 to 2028.
Expansion of Pipeline of Lyophilized Injectable Drugs
The continuous research to invent drugs to treat chronic diseases has driven the development of lyophilized injectable drugs in the pharmaceutical industry. Product innovation and strategic activities by critical key players provide opportunities to penetrate a new therapeutic area/market. Approximately 2,400 injectable products are present in the development pipeline. Drug developers are increasingly interested in the lyophilization technique as it can extend the shelf life of small and large-molecule drugs. The prevalence of formulation stability challenges for complex APIs and biologics resulted in more pharmaceutical and biopharmaceutical manufacturers turning to lyophilization. The use of lyophilization for pharmaceutical and biopharmaceutical product manufacturing has grown by ~13.5% per year in the past five years. Because liquids are the preferred formulation for commercial-scale production of many parenteral products, lyophilization is increasingly essential in bringing liquid products to market. Lyophilization is significant for two reasons; increasing the number of new drug applications and decreasing review times for new drug approvals. More than 3,000 drug candidates are in the pipeline in therapeutic areas where parenteral delivery dominates. Of these 3,000 products, ~2,250 are in pre-clinical development/Phase I. Of the remaining candidates, ~750 are in Phase II and III. This pipeline of lyophilized products will add to the established list of lyophilized drugs in the upcoming period. Thus, it is expected to augment the lyophilized injectable market.Market Overview
MEA Lyophilized Injectable Market Segmentation
The MEA lyophilized injectable market is segmented based on type of packaging, type of delivery, indication, end user, and country.- Based on type of packaging, the MEA lyophilized injectable market is segmented into single-use vials, point-of-care reconstitution, and specialty packaging. The single-use vials segment held the largest market share in 2022.
- Based on indication, the MEA lyophilized injectable market is categorized into metabolic and oncology conditions, infectious diseases, autoimmune diseases, and others. The metabolic and oncology conditions segment held the largest market share in 2022.
- Based on end user, the MEA lyophilized injectable market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. The hospitals segment held the largest market share in 2022.
- Based on country, the MEA lyophilized injectable market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of MEA. South Africa dominated the market in 2022.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Lyophilized Injectable Market - By Type of Packaging
1.3.2 MEA Lyophilized Injectable Market - By Type of Delivery
1.3.3 MEA Lyophilized Injectable Market - By Indication
1.3.4 MEA Lyophilized Injectable Market - By End User
1.3.5 MEA Lyophilized Injectable Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Lyophilized Injectable Market - Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Lyophilized Injectable Market- Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Demand for Contract Research Manufacturing Services
5.1.2 Increasing Demand of Biologics
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Expansion of Pipeline of Lyophilized Injectable Drugs
5.4 Future Trends
5.4.1 Advancement in Lyophilized Packaging
5.5 Impact Analysis
6. Lyophilized Injectable Market- MEA Analysis
6.1 MEA Lyophilized Injectable Market Revenue Forecast and Analysis
7. MEA Lyophilized Injectable Market Analysis - By Type of Packaging
7.1 Overview
7.2 MEA Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)
7.3 Single-use vials
7.3.1 Overview
7.3.2 Single-use vials: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Point-of-Care Reconstitution
7.4.1 Overview
7.4.2 Point-of-Care Reconstitution: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Specialty Packaging
7.5.1 Overview
7.5.2 Specialty Packaging: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8. MEA Lyophilized Injectable Market Analysis - By Type of Delivery
8.1 Overview
8.2 MEA Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)
8.3 Prefilled Diluent Syringes
8.3.1 Overview
8.3.2 Prefilled Diluent Syringes: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Single Step Devices
8.4.1 Overview
8.4.2 Single Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Proprietary Reconstitution Devices
8.5.1 Overview
8.5.2 Proprietary Reconstitution Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Multi-Step Devices
8.6.1 Overview
8.6.2 Multi-Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9. MEA Lyophilized Injectable Market Analysis - By Indication
9.1 Overview
9.2 MEA Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)
9.3 Metabolic and Oncology Conditions
9.3.1 Overview
9.3.2 Metabolic and Oncology Conditions: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Infectious Diseases
9.4.1 Overview
9.4.2 Infectious Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Autoimmune Diseases
9.5.1 Overview
9.5.2 Autoimmune Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Other Indications
9.6.1 Overview
9.6.2 Other Indications: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10. MEA Lyophilized Injectable Market Analysis - By End User
10.1 Overview
10.2 MEA Lyophilized Injectable Market, by End User, 2021 and 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Specialty Clinics
10.5.1 Overview
10.5.2 Specialty Clinics: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.6 Other End Users
10.6.1 Overview
10.6.2 Other End Users: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
11. MEA Lyophilized Injectable Market - Country Analysis
11.1 Overview
11.1.1 MEA: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
11.1.1.1 South Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.1.1 Overview
11.1.1.1.2 South Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.1.3 South Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ ‘Million)
11.1.1.1.4 South Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ ‘Million)
11.1.1.1.5 South Africa: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ ‘Million)
11.1.1.1.6 South Africa: Lyophilized Injectable Market, by End User, 2019-2028 (US$ ‘Million)
11.1.1.2 Saudi Arabia: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.2.1 Overview
11.1.1.2.2 Saudi Arabia: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.2.3 Saudi Arabia: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ ‘Million)
11.1.1.2.4 Saudi Arabia: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ ‘Million)
11.1.1.2.5 Saudi Arabia: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ ‘Million)
11.1.1.2.6 Saudi Arabia: Lyophilized Injectable Market, by End User, 2019-2028 (US$ ‘Million)
11.1.1.3 UAE: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.3.1 Overview
11.1.1.3.2 UAE: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.3.3 UAE: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ ‘Million)
11.1.1.3.4 UAE: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ ‘Million)
11.1.1.3.5 UAE: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ ‘Million)
11.1.1.3.6 UAE: Lyophilized Injectable Market, by End User, 2019-2028 (US$ ‘Million)
11.1.1.4 Rest of MEA: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.4.1 Overview
11.1.1.4.2 Rest of MEA: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
11.1.1.4.3 Rest of MEA: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ ‘Million)
11.1.1.4.4 Rest of MEA: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ ‘Million)
11.1.1.4.5 Rest of MEA: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ ‘Million)
11.1.1.4.6 Rest of MEA: Lyophilized Injectable Market, by End User, 2019-2028 (US$ ‘Million)
12. Industry Landscape
12.1 Overview
12.2 Inorganic Growth Strategies
12.2.1 Overview
12.3 Organic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 Baxter
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Nipro
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Recipharm AB
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Vetter Pharma
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Jubilant HollisterStier (Jubilant Pharma Limited)
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Aristopharma Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Credence MedSystems, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 S.G. Biopharm Pvt. Ltd.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
List of Tables
Table 1. MEA Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. South Africa: Lyophilized Injectable Market, by Type Of Packaging - Revenue and Forecast to 2028 (US$ ‘Million)
Table 3. South Africa: Lyophilized Injectable Market, by Type Of Delivery - Revenue and Forecast to 2028 (US$ ‘Million)
Table 4. South Africa: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. South Africa: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. Saudi Arabia: Lyophilized Injectable Market, by Type Of Packaging - Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. Saudi Arabia: Lyophilized Injectable Market, by Type Of Delivery - Revenue and Forecast to 2028 (US$ ‘Million)
Table 8. Saudi Arabia: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 9. Rest of Middle East and Africa: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ ‘Million)
Table 10. UAE: Lyophilized Injectable Market, by Type Of Packaging - Revenue and Forecast to 2028 (US$ ‘Million)
Table 11. UAE: Lyophilized Injectable Market, by Type Of Delivery - Revenue and Forecast to 2028 (US$ ‘Million)
Table 12. UAE: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 13. UAE: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ ‘Million)
Table 14. Rest of MEA: Lyophilized Injectable Market, by Type Of Packaging - Revenue and Forecast to 2028 (US$ ‘Million)
Table 15. Rest of MEA: Lyophilized Injectable Market, by Type Of Delivery - Revenue and Forecast to 2028 (US$ ‘Million)
Table 16. Rest of MEA: Lyophilized Injectable Market, by Indication - Revenue and Forecast to 2028 (US$ ‘Million)
Table 17. Rest of MEA: Lyophilized Injectable Market, by End User - Revenue and Forecast to 2028 (US$ ‘Million)
Table 18. Recent Inorganic Growth Strategies
Table 19. Recent Organic Growth Strategies
Table 20. Glossary of Terms
List of Figures
Figure 1. MEA Lyophilized Injectable Market Segmentation
Figure 2. MEA Lyophilized Injectable Market - By Country
Figure 3. MEA Lyophilized Injectable Market Overview
Figure 4. MEA Lyophilized Injectable Market, By Type of Packaging
Figure 5. MEA Lyophilized Injectable Market, By Country
Figure 6. MEA: PEST Analysis
Figure 7. Experts Opinion
Figure 8. MEA Lyophilized Injectable Market Impact Analysis of Drivers and Restraints
Figure 9. MEA Lyophilized Injectable Market- Revenue Forecast and Analysis
Figure 10. MEA Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)
Figure 11. MEA Single-use vials: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. MEA Point-of-Care Reconstitution: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. MEA Specialty Packaging: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. MEA Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)
Figure 15. MEA Prefilled Diluent Syringes: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. MEA Single Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. MEA Proprietary Reconstitution Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. MEA Multi-Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. MEA Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)
Figure 20. MEA Metabolic and Oncology Conditions: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. MEA Infectious Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. MEA Autoimmune Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. MEA Other Indications: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. MEA Lyophilized Injectable Market, by End User, 2021 and 2028 (%)
Figure 25. MEA Hospitals: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. MEA Ambulatory Surgical Centers: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. MEA Specialty Clinics: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. MEA Other End Users: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. MEA: Lyophilized Injectable Market, by Key Country - Revenue (2021) (US$ ‘Million)
Figure 30. MEA: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
Figure 31. South Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 32. Saudi Arabia: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 33. UAE: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
Figure 34. Rest of MEA: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ ‘Million)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aristopharma Ltd.
- Baxter
- Credence MedSystems, Inc.
- Jubilant HollisterStier (Jubilant Pharma Limited)
- Nipro
- Recipharm AB
- S.G. Biopharm Pvt. Ltd.
- Vetter Pharma
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 123 |
| Published | December 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 82.87 Million |
| Forecasted Market Value ( USD | $ 101.86 Million |
| Compound Annual Growth Rate | 3.5% |
| Regions Covered | Africa, Middle East |
